11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      World Health Organization’s Growth Reference Overestimates the Prevalence of Severe Malnutrition in Children with Sickle Cell Anemia in Africa

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Anthropometric indices are widely used to assess the health and nutritional status of children. We tested the hypothesis that the 2007 World Health Organization (WHO) reference for assessment of malnutrition in children with sickle cell anemia (SCA) overestimates the prevalence of severe malnutrition when compared to a previously constructed SCA-specific reference. We applied the WHO and SCA-specific references to children with SCA aged 5–12 years living in northern Nigeria (Primary Prevention of Stroke in Children with SCA in sub-Saharan Africa (SPRING) trial) to determine the difference in prevalence of severe malnutrition defined as body mass index (BMI) Z-score <−3 and whether severe malnutrition was associated with lower mean hemoglobin levels or abnormal transcranial Doppler measurements (>200 cm/s). A total of 799 children were included in the final analysis (median age 8.2 years (interquartile range (IQR) 6.4–10.4)). The application of the WHO reference resulted in lower mean BMI than the SCA-specific reference (−2.3 versus −1.2; p < 0.001, respectively). The use of the WHO reference when compared to the SCA-specific reference population also resulted in a higher prevalence of severe malnutrition (28.6% vs. 6.4%; p < 0.001). The WHO reference significantly overestimates the prevalence of severe malnutrition in children with SCA when compared to an SCA-specific reference. Regardless of the reference population, severe malnutrition was not associated with lower mean hemoglobin levels or abnormal transcranial Doppler (TCD) measurements.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Growth curve for girls with Turner syndrome.

          A growth chart for girls with Turner syndrome has been prepared using data from four published series of European patients, and evaluated using retrospective data on the heights of girls with Turner syndrome seen at this hospital. The results indicate that calculation of height standard deviation score from this chart allows a reasonable prediction of adult stature in any patient with Turner syndrome. In addition, the results indicate that while oestrogen treatment causes an initial acceleration of growth, it has no significant effect on adult height.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Growth charts for Down's syndrome from birth to 18 years of age.

            Growth in children with Down's syndrome (DS) differs markedly from that of normal children. The use of DS specific growth charts is important for diagnosis of associated diseases, such as coeliac disease and hypothyroidism, which may further impair growth. To present Swedish DS specific growth charts. The growth charts are based on a combination of longitudinal and cross sectional data from 4832 examinations of 354 individuals with DS (203 males, 151 females), born in 1970-97. Mean birth length was 48 cm in both sexes. Final height, 161.5 cm for males and 147.5 cm for females, was reached at relatively young ages, 16 and 15 years, respectively. Mean birth weight was 3.0 kg for boys and 2.9 kg for girls. A body mass index (BMI) >25 kg/m(2) at 18 years of age was observed in 31% of the males and 36% of the females. Head growth was impaired, resulting in a SDS for head circumference of -0.5 (Swedish standard) at birth decreasing to -2.0 at 4 years of age. Despite growth retardation the difference in height between the sexes is the same as that found in healthy individuals. Even though puberty appears somewhat early, the charts show that DS individuals have a decreased pubertal growth rate. Our growth charts show that European boys with DS are taller than corresponding American boys, whereas European girls with DS, although being lighter, have similar height to corresponding American girls.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease.

              Previous studies of children with sickle cell disease (SCD) reported poor growth and delayed maturation. However, the prevalence, magnitude, and correlates of suboptimal growth remain poorly understood. A prospective longitudinal study was undertaken to determine the effects of disease severity and nutritional status on growth, an indicator of childhood well-being. Children, birth to 18 y of age, with SCD-SS were evaluated annually for 4 y. Growth, nutritional status, skeletal and sexual maturation, disease severity, dietary intake, and maternal education were assessed. In this sample of 148 children (78 females), growth in height, weight, or body mass index declined in 84% of subjects; 38% fell below the 5th percentile in one or more measures. Puberty was delayed 1 to 2 y, and median age at menarche was 13.2 y. Skeletal age was delayed by 0.7 +/- 1.4 y overall and by 1.3 +/- 1.5 y in children 10 to 15 y old. Height status declined over time and was positively associated with advancing puberty and hematological measures in girls, and nutritional status in girls and boys. Growth failure and maturational delay remain significant chronic problems in children with SCD-SS and are related to potentially modifiable factors such as nutritional status.
                Bookmark

                Author and article information

                Journal
                J Clin Med
                J Clin Med
                jcm
                Journal of Clinical Medicine
                MDPI
                2077-0383
                02 January 2020
                January 2020
                : 9
                : 1
                : 119
                Affiliations
                [1 ]Vanderbilt-Meharry Sickle Cell Center for Excellence, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37203, USA; Djamila.labib@ 123456vumc.org (D.L.G.); Brittany.covert@ 123456vumc.org (B.C.G.)
                [2 ]Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, 700233 Kano, Nigeria; Dr_suak@ 123456yahoo.com
                [3 ]Department of Pediatrics, Murtala Mohammed Specialist Hospital, 700251 Kano, Nigeria; Bintajibir@ 123456gmail.com (B.W.J.); Saphiaaa01@ 123456gmail.com (S.G.)
                [4 ]Department of Hematology and Blood Transfusion, Barau Dikko Teaching Hospital/Kaduna State University, 800241 Kaduna, Nigeria; Mamanzara@ 123456yahoo.co.uk
                [5 ]Department of Pediatrics, Barau Dikko Teaching Hospital/Kaduna State University, 800241 Kaduna, Nigeria; Drdaddy002@ 123456yahoo.com
                [6 ]Department of Administration, Aminu Kano Teaching Hospital, 700233 Kano, Nigeria; Khadijabulama@ 123456yahoo.com (K.B.); ufahd@ 123456yahoo.com (F.M.U.)
                [7 ]Department of Administration, Murtala Muhammad Specialist Hospital, 700251 Kano, Nigeria; Awwalgambo@ 123456gmail.com
                [8 ]Department of Health Policy, Vanderbilt Institute for Global Health, Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Muktar.aliyu@ 123456vumc.org
                [9 ]Department of Hematology and Oncology, Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Adetola.kassim@ 123456vumc.org
                [10 ]Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37203, USA; james.c.slaughter@ 123456vumc.org
                [11 ]Rodeghier Consultants Chicago, Chicago, IL 60631, USA; Markrodeghier@ 123456comcast.net
                Author notes
                [* ]Correspondence: m.debaun@ 123456vumc.org ; Tel.: +615-875-3040; Fax: +615-875-3055
                Author information
                https://orcid.org/0000-0001-9993-4548
                https://orcid.org/0000-0002-0574-1604
                Article
                jcm-09-00119
                10.3390/jcm9010119
                7020064
                31906442
                1f5fc3c3-3f24-4a7f-9aa6-1c289182d938
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 23 October 2019
                : 22 December 2019
                Categories
                Article

                sickle cell disease,growth references,severe malnutrition

                Comments

                Comment on this article